Michael Byrnes - 14 Feb 2024 Form 3 Insider Report for PHOENIX BIOTECH ACQUISITION CORP. (CERO)

Role
Director
Signature
/s/ Charles Carter, attorney-in-fact
Issuer symbol
CERO
Transactions as of
14 Feb 2024
Net transactions value
$0
Form type
3
Filing time
16 Feb 2024, 19:27:49 UTC
Previous filing
16 Nov 2023
Next filing
21 Feb 2024

No securities are beneficially owned.

Remarks:

Exhibit 24 - Power of Attorney. Effective immediately after the Effective Time as defined in that certain Business Combination Agreement dated as of June 4, 2023, as amended, by and among the Issuer (f/k/a Phoenix Biotech Acquisition Corp.), CERo Therapeutics, Inc. and PBCE Merger Sub, Inc., the reporting person was elected as a member of the board of directors of the Issuer.